Klingman & Associates, LLC Amgen Inc Transaction History

Klingman & Associates, LLC

$1.48 Billion
Q2 2024

A detailed history of Klingman & Associates, LLC transactions in Amgen Inc stock. As of the latest transaction made, Klingman & Associates, LLC holds 1,196 shares of AMGN stock, worth $377,936. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,196

Previous 1,248 4.17%

Holding current value

$377,936

Previous $354,000 5.37%

% of portfolio

0.03%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$262.75 - $319.31 $13,663 - $16,604	-52 Reduced 4.17%	1,196 $373,000
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $16,938 - $20,447	63 Added 5.32%	1,248 $354,000
Q4 2023 Jan 29, 2024	BUY	$255.7 - $288.46 $3,068 - $3,461	12 Added 1.02%	1,185 $341,000
Q3 2023 Oct 30, 2023	SELL	$218.65 - $271.46 $5,903 - $7,329	-27 Reduced 2.25%	1,173 $315,000
Q2 2023 Jul 31, 2023	BUY	$214.27 - $253.37 $56,353 - $66,636	263 Added 28.07%	1,200 $266,000
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $12,644 - $15,411	56 Added 6.36%	937 $226,000
Q4 2022 Feb 03, 2023	SELL	$229.03 - $291.01 $9,619 - $12,222	-42 Reduced 4.55%	881 $231,000
Q3 2022 Oct 28, 2022	BUY	$224.46 - $253.15 $4,489 - $5,063	20 Added 2.21%	923 $208,000
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $461 - $513	-2 Reduced 0.22%	903 $220,000
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $108,319 - $119,829	-494 Reduced 35.31%	905 $218,000
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $50,714 - $58,038	255 Added 22.29%	1,399 $315,000
Q1 2021 Apr 29, 2021	BUY	$221.91 - $258.6 $3,328 - $3,879	15 Added 1.33%	1,144 $285,000
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $1,514 - $1,803	-7 Reduced 0.62%	1,129 $260,000
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $266,562 - $296,439	1,136 New	1,136 $289,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingman & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Klingman & Associates, LLC with notifications on news.

Account

Klingman & Associates, LLC Amgen Inc Transaction History